I'm not sure on what to make of the Gilead comment to be honest @jwoody1000.
I believe there are discussions as it formed a part of the presentation, JF commented 3 - 5 mls as opposed to 300mls. I'm not Gilead but that sure would bring the cost down of the drug down as well as a wider delivery platform (ie o/s of intensive care situations). That opens up the third world dramatically, which will be last for any vaccine and gives Gilead a longer life span on remdisivir?
Ann: AGM Chairman address and CEO presentation, page-36
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |